This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Invacare Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Geoff Purtill

Algemeen directeur

US$918.3k

Totale compensatie

Percentage CEO-salaris	53.0%
Dienstverband CEO	less than a year
Eigendom CEO	0.07%
Management gemiddelde ambtstermijn	2.8yrs
Gemiddelde ambtstermijn bestuur	3.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Geoff Purtill's beloning veranderd ten opzichte van Invacare's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Dec 31 2022	US$918k	US$486k	-US$101m

Compensatie versus markt: Geoff's total compensation ($USD918.28K) is above average for companies of similar size in the German market ($USD435.93K).

Compensatie versus inkomsten: Insufficient data to compare Geoff's compensation with company performance.

CEO

Geoff Purtill (52 yo)

less than a year

Tenure

US$918,284

Compensatie

Mr. Geoffrey P. Purtill, also known as Geoff, serves as President and Chief Executive Officer at Invacare Corporation since November 2022 and serves as its Director since December 09, 2022 and served as it...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Geoffrey Purtill	CEO, President & Director	less than a year	US$918.28k	0.073% $ 381.3
Kathleen Leneghan	Senior VP & CFO	5.5yrs	US$777.11k	0.34% $ 1.8k
Anthony LaPlaca	Senior VP	14.3yrs	US$561.04k	0.23% $ 1.2k
Lois Lee	Director of Treasury & Investor Relations	no data	geen gegevens	geen gegevens
Cintia Ferreira	Chief Human Resources Officer	less than a year	geen gegevens	geen gegevens
Joost Beltman	Senior Vice President of Commercial Operations & Central	2.8yrs	US$800.41k	0.053% $ 274.9

2.8yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: IV3's management team is considered experienced (2.8 years average tenure).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Geoffrey Purtill	CEO, President & Director	less than a year	US$918.28k	0.073% $ 381.3
Aron Schwartz	Independent Director	1.2yrs	US$118.63k	geen gegevens
Edward Crawford	Independent Director	less than a year	US$31.11k	geen gegevens
Michael Merriman	Independent Non-Executive Chairman	9yrs	US$170.95k	geen gegevens
Clifford Nastas	Lead Independent Director	8yrs	US$162.46k	0.23% $ 1.2k
Steven Rosen	Independent Director	less than a year	US$31.11k	geen gegevens
Marc Gibeley	Independent Director	7.5yrs	US$165.67k	0.18% $ 960.2
Petra Danielsohn-Weil	Independent Director	5yrs	US$144.92k	0.14% $ 719.8

3.1yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: IV3's board of directors are considered experienced (3.1 years average tenure).

This company listing is no longer active

Invacare Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Invacare Corporation Appoints Geoffrey P. Purtill as President

Invacare Corporation Announces Executive Changes

Invacare Corporation Announces Board and Committee Appointments

Invacare Corporation, Annual General Meeting, May 19, 2022

Independent Director recently sold €50k worth of stock

Recent updates

Invacare Corporation(OTCPK:IVCR.Q) dropped from S&P TMI Index

NYSE to Suspend Trading Immediately in Invacare Corporation and Commence Delisting Proceedings

Invacare Corporation Filed for Bankruptcy

Invacare Corporation Filed for Bankruptcy

Invacare Corporation Appoints Geoffrey P. Purtill as President

Third quarter 2022 earnings released: US$0.92 loss per share (vs US$0.65 loss in 3Q 2021)

Invacare Corporation to Report Q3, 2022 Results on Nov 07, 2022

Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule

Invacare Corporation Announces Executive Changes

Invacare Corporation Announces Board and Committee Appointments

Second quarter 2022 earnings released

Invacare Corporation to Report Q2, 2022 Results on Aug 08, 2022

Invacare Corporation(NYSE:IVC) dropped from Russell 2000 Value Index

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

First quarter 2022 earnings released: US$0.69 loss per share (vs US$0.41 loss in 1Q 2021)

Invacare Corporation Reaffirms Revenue Guidance for the Full Year 2022

Invacare Corporation to Report Q1, 2022 Results on May 09, 2022

Invacare Corporation, Annual General Meeting, May 19, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Invacare Corporation to Report Q4, 2021 Results on Mar 08, 2022

Invacare Corporation Introduces Its Next Generation E-Fix Eco Power Assist Device to Transform the Manual Wheelchair

Invacare Corporation Introduces New, Narrow Version of Invacare® AVIVA® STORM RX™ Rear Wheel Drive Power Wheelchair

Invacare Announces New Features in LiNX® 3 Electronics

Senior VP & GM of EMEA Ralf Ledda has left the company

No longer forecast to breakeven

Third quarter 2021 earnings released: US$0.65 loss per share (vs US$0.21 loss in 3Q 2020)

Forecast to breakeven in 2023

Invacare Corporation Provides Sales Guidance for the Third Quarter and Full Year 2021

Independent Director Baiju Shah has left the company

Independent Director recently sold €50k worth of stock

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.48 loss in 2Q 2020)

Invacare Corporation Introduces the Invacare® AVIVA STORM RX, a Next Generation Rear Wheel Drive Power Wheelchair

First quarter 2021 earnings released: US$0.41 loss per share (vs US$0.022 profit in 1Q 2020)

Invacare Corporation Reaffirms Earnings Guidance for the Full Year 2021

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations

Invacare Corporation and Its Subsidiary, Alber Usa, LLC Introduces the Next Generation Alber E-Motion® Power Assist Device

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations

Invacare Corporation to Report Q4, 2020 Results on Feb 10, 2021

New 90-day high: €8.20

New 90-day high: €7.90

New 90-day high: €7.50

Invacare Corporation Launches the AVIVA™ FX – MPS Maxx Multi-Position Power Standing System

Third-quarter earnings released: Revenue beats expectations

Third quarter earnings released

Invacare Corporation to Report Q3, 2020 Results on Oct 29, 2020

Invacare Corporation Introduces New ISA™ Premier Series Stand Assist Lifts Into the U.S. Market

New 90-day high: €6.85

New 90-day low - €5.30

First half earnings released

Invacare Corporation to Report Q2, 2020 Results on Aug 05, 2020

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd